Biggest News Aggregation in the World
📰 Linkedin News

Page 117 - Linkedin News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Linkedin. Real-time updates on events, politics, business and more.

U.S. Food and Drug Administration Approves Bristol Myers Squibb's Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma

Bristol Myers Squibb (NYSE: BMY) today announced the U.S. Food and Drug Administration (FDA) has granted approval for Breyanzi ® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment of adult patients with relapsed or refractory mantle cell lymphoma ...
United Kingdom United States Hemophagocytic Lymphohistiocytosis Meghan Gutierrez Bristol Myers Squibb Michael Wang

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science